4//SEC Filing
Knappertz Volker 4
Accession 0001628280-23-006527
CIK 0001600620other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:28 PM ET
Size
5.3 KB
Accession
0001628280-23-006527
Insider Transaction Report
Form 4
Knappertz Volker
EVP, Research and Development
Transactions
- Award
Common Stock
2023-03-02+191,462→ 344,274 total
Footnotes (3)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 191,462 newly awarded RSUs and 152,812 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning August 1, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001754122
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:28 PM ET
- Size
- 5.3 KB